Navigation Links
Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
Date:2/9/2011

MORRISTOWN, N.J., Feb. 9, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252 (the "'252 Patent").

The Company said it is continuing to seek final FDA approval of the products.

In 2009, Reckitt Benckiser sued Watson Laboratories, Inc. for patent infringement related to the generic versions of Mucinex®.  The Mucinex® products had total U.S. sales of approximately $500 million for the twelve months ending December 31, 2010, according to IMS Health and IRI and are indicated to help loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.  

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release.  It is important to note tha
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2010 Earnings
2. Watson Confirms Welchol® Oral Suspension Patent Challenge
3. Watson Presents Outlook for Continued Long Term Growth
4. Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
5. Watson Announces Preliminary Financial Performance for FY 2010
6. Watson to Host Investor Day on January 21 in New York City
7. Watsons Generic Fentora® Receives FDA Approval
8. Watson to Present at the 29th Annual JP Morgan Healthcare Conference
9. Watson Announces Novel Oral Contraceptive Approval
10. Watson and Richter Announce Exclusive License Agreement for Esmya™
11. Watson Confirms Exalgo™ Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... (OFT) approval condition to the announced tender offer for all of ... As a result of the waiver, the transaction is no longer ... offer on January 24, 2014 following the currently scheduled expiration time, ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Pharmaceutical Inc. (Nasdaq: BMRN ) today ... BioMarin, will host a conference call and webcast ... to discuss fourth quarter and full year 2010 ... Number:  617.213.8848Participant Code: 90635895Replay Dial-in Number: 888.286.8010Replay International ...
... Matrixx Initiatives, Inc. (Nasdaq: MTXX ... company that develops and markets Zicam® products, today ... for in the previously announced merger agreement, dated ... Matrixx, Wonder Holdings, Inc. ("Wonder") and Wonder Holdings ...
Cached Medicine Technology:BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results 2Matrixx Initiatives, Inc. Announces End of 'Go-Shop' Period 2Matrixx Initiatives, Inc. Announces End of 'Go-Shop' Period 3
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... NEW YORK, NY (April 16, 2014) The cause ... but a new study proposes that neurons may be ... own immune system, similar to the way autoimmune diseases ... attack the body,s cells. The study was published April ... is a new, and likely controversial, idea in Parkinson,s ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
(Date:4/17/2014)... NEW YORK April 17, 2014 EcoHealth Alliance, ... public health issues, published a comprehensive review today examining ... and Marburg virus. The review calls for improved global ... such as the recent outbreak of Ebola in West ... in the countries of Guinea and Liberia. According ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2
... According to a survey done by the U.S. government it was ... among the America's elderly population//. It is said that adults aged ... estimated that the number of people addicted to drug would double ... generation is addicted to drugs due to problems such as pain, ...
... Drug addiction is becoming a significant public health probelm ... that the number of individuals with drug addiction// problems ... of 2020. ,Nearly 2.5 million Americans have ... 1999. The increasing inclination of elders to take drugs ...
... collaborate to prove through clinical trials the efficacy of ... known to cure but for which there is no ... collaboration has been approved by the board members and ... to the government for seeking funding," said Ranjit Roy ...
... has confirmed five more bird flu related deaths in Indonesia, ... team has further been sent to the northern Sumatra region, ... same family) had lived. The fifth victim was a 38-year-old ... and meat. ,,It is further suspected that eight ...
... helps to protect the lungs of premature infants from ... McMaster University researchers have reported// an early finding in ... caffeine therapy for the treatment of apnoea of prematurity. ... preterm infants, because the lungs are underdeveloped and the ...
... will not be allowed to make tall claims on their ... EU lawmakers have clamped down on misleading claims or health ... to set a common standard for vitamins, minerals and food ... manufacturers who are not able to justify their claims will ...
Cached Medicine News:Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 2Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 3Health News:Caffeine Therapy May Help Protect Lungs Of Premature Babies 2
... many as three tests confirmed Sterillium Rub's ... according to FDA (Time Kill study and ... Drug Products) and one European test - ... the relevant international efficacy specifications. Sterillium Rub ...
HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols....
... All of The Scrub Care® ... are formulated for the ultimate in ... harmful bacteria while keeping skin healthy ... use. This solutions do not contain ...
Exidine® 2% CHG Brushless Surgical Scrub offers exceptional persistence and broad-spectrum antimicrobial activity....
Medicine Products: